Germany· DE-A57-fec099d717db913c
Nipent
A pentostatin product containing pentostatin, registered in Germany by Pfizer Pharma Gmbh. The same ATC class is registered in 5 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Pentostatin is registered in 5 of 19 countries.
Countries holding a registration under ATC L01XX08 (pentostatin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 2 of them publish a price we can compare per daily dose
Pentostatin · ATC L01XX08
5 / 19 countries
- Franceprice
- Germany
- Ireland
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Pentostatin
- Manufacturer
- Pfizer Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- L01XX08
- ATC class
- Pentostatin
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
130 interactions on record for pentostatin.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pentostatin · interactions on record
130 records
- 31 severe
- 83 moderate
- 16 minor
Most severe, free to view
- CladribineL01BB04severe
- FludarabineL01BB05severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pentostatin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesNipentHospira, Inc.
- SpainNIPENT 10 mg POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIONPfizer S.L.
- FranceNIPENT 10 mg, poudre pour solution pour injection, poudre pour solution pour perfusionPFIZER HOLDING FRANCE
- United KingdomNipent 10mg powder for solution for injection vialsPfizer Ltd
- IrelandNIPENT 10 mg powder for solution for injection, powder for solution for infusionPfizer Healthcare Ireland Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Spain · Nipent
- France · Nipent
- United Kingdom (Northern Ireland) · Nipent
- Greece · Nipent
- Ireland · Nipent
- Italy · Nipent
- Malta · Nipent
- Portugal · Nipent
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c569ac8e-95fd-4eca-aa3d-056c290e66eb GET /v1/drugs/c569ac8e-95fd-4eca-aa3d-056c290e66eb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Pentostatin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about pentostatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.